Physician profile
James C Wright
NPI 1053390781
$956.07
in general payments reported to CMS, 2019-2025
20 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $11.09 · 2021: $137 · 2022: $165 · 2023: $276 · 2024: $158 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $540.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $346.68 | 2021-2025 | Ubrelvy, Qulipta, Vraylar |
| Baxter Healthcare | $66.22 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Pfizer INC. | $63.51 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $61.89 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $46.73 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.71 | 2024-2025 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $38.56 | 2022-2024 | Farxiga |
| Dexcom, INC. | $36.00 | 2024 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $32.28 | 2019-2025 | Ozempic |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.96 | 2021-2023 | Xifaxan, Trulance |
| Lilly USA, LLC | $30.96 | 2023-2024 | Mounjaro |
| Exact Sciences Corporation | $29.10 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Sunovion Pharmaceuticals INC. | $20.94 | 2019 | |
| Amarin Pharma, INC. | $17.93 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $16.19 | 2023 | Myrbetriq |
| Amgen INC. | $13.74 | 2025 | Evenity |
| Janssen Pharmaceuticals, INC | $13.30 | 2019 | |
| Mylan Specialty L.P. | $13.28 | 2023 | Yupelri |
| Allergan, INC. | $11.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.